• Mihajlović Health Analytics (MiHA) •
Your consultant in health economics

PUBLICATIONS & EXPERIENCE

MiHA centred its research on methodological aspect of modelling innovative cancer therapies, in particular on survival analysis and simultaneous comparisons of such treatments through network meta-analyses. MiHA also conducted research in the field of cancer epidemiology, pharmacoepidemiology and analysed different reimbursement policies in area of oncology. Most of this research was firstly published in peer-reviewed journals and later contributed to the thesis “Health Economics of Targeted Cancer Therapies”, partly available HERE

Additionally, we provide links for selected journal publications and conference podium and poster presentations done by Jovan/MiHA in period 2010-2015:

• Mihajlović J, Pechlivanoglou P, Miladinov-Mikov M, Živković S, Postma MJ
  Cancer incidence and mortality in Serbia 1999-2009


• Mihajlović J, Pechlivanoglou P, Sabo A, Tomić Z, Postma MJ
  Cost-effectiveness and budget impact analysis of everolimus for second-line treatment of metastatic renal cell cancer in Serbia


• Mihajlović J, Postma MJ
  Network meta-analysis of overall and progression free survival of first line metastatic renal cell targeted therapies


• Mihajlović J, Dolk C, Tolley K, Simoens S, Postma MJ
  Reimbursement of targeted cancer therapies within three different European health care systems


• Mihajlović J, Minović I, Bruinsma A, Postma MJ
  Cost utility analysis of everolimus in the treatment of metastatic renal cell cancer in the Netherlands


• Mihajlović J, Pechlivanoglou P, Postma MJ
  Cost effectiveness of cervical cancer screening in Serbia. A comparison of screening policies


• Mihajlović J, Bax P, van Breugel E, Blommestein HM, Hoogendoorn M, Hospes W, Postma MJ
  Micro-costing study of rituximab subcutaneous injection versus intravenous infusion


• Mihajlović J, Hovius JWR, Sprong H, Bogovič P, Postma MJ, Strle F
  Cost-effectiveness of a potential anti-tick vaccine with combined protection against Lyme borreliosis and tick-borne encephalitis in Slovenia.

 

Apart from the thesis, MiHA was outsourced by the industry for creation, adjustment or validation of mathematical models, completion of cost-effectiveness and budget impact analyses and preparation of pharmacoeconomic dossiers. An invaluable experience was gained in modelling of drugs designed for following therapeutic areas:

Metastatic cancers (renal cell, breast, lung, prostate, colorectal, ovarian, gastric and skin cancer)

Haematology (lymphoma and myeloma)

Endocrinology (diabtes mellitus)

Rheumatology (rheumatoid arthritis)

Infectious diseases (hepatitis C virus, tick-borne diseases)

Ophthalmology (age-related macular degeneration, diabetic macular edema)

Renal diseases (renal insufficiency, hyperphosphatemia)

Cardiology (stabile angina and heart failure)

Omladinskih radnih akcija 54,
21000 Novi Sad
Serbia

Phone : +381 21 6414 272
Mobile : +381 63 682 465

E-mail : jovan@miha.rs
Skype : MiHA